Multiple Myeloma
Conditions
Brief summary
Extension of patient follow-up of the IFM/DFCI 2009 study over a period of 4 years (that is, from 01 December 2016 to 30 November 2020) during which patients will be followed up in the normal course of care and according to the usual care of the centers, with collection of the needed data about twice a year by the investigators
Interventions
None listed
Sponsors
University Hospital, Toulouse
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patient randomized in the IFM/DFCI 2009 study. * Patient still alive must give their non-opposition to the post IFM/DFCI 2009 study data collection until 30 November 2020 * Patient non-opposition.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| progression free survival | 4 years | number of deaths |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| overall long-term survival | 4 years | number of deaths |
| secondary primary malignancies | 4 years | number of secondary primary malignancies |
Countries
France
Contacts
Primary ContactMichel ATTAL, MD PhD
Backup ContactLaura BOGDANOVITCH
Outcome results
None listed